Page last updated: 2024-09-04

cryptotanshinone and Cardiomyopathies

cryptotanshinone has been researched along with Cardiomyopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Li, F; Shu, J; Wang, H; Yao, Y; Ying, MZ; Zhang, Y	1

Other Studies

1 other study(ies) available for cryptotanshinone and Cardiomyopathies

Article	Year
Cryptotanshinone protects against adriamycin-induced mitochondrial dysfunction in cardiomyocytes. Pharmaceutical biology, 2016, Volume: 54, Issue:2 Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Drugs, Chinese Herbal; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Phenanthrenes; Rats, Wistar; Salvia miltiorrhiza	2016

Article

Year

Cryptotanshinone protects against adriamycin-induced mitochondrial dysfunction in cardiomyocytes.

Pharmaceutical biology, 2016, Volume: 54, Issue:2

Topics: Adenosine Triphosphate; Animals; Cardiomyopathies; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Drugs, Chinese Herbal; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Phenanthrenes; Rats, Wistar; Salvia miltiorrhiza

2016